About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood ...
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...
Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...
The gene p53 acts as a tumor suppressor and often is called the ‘guardian of the genome.’ This gene is central to maintaining genomic stability, which prevents mutations from accumulating and leading ...
Up to 5% of Americans may carry genetic variants associated with cancer risk, according to a cross-sectional analysis.The ...
The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...
Precision and timing of gene expression is essential for normal biological functions and, when disrupted, can lead to many ...
Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...
From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...